Skip to main content

Fernàndez Garberi, Caterina

Institutions of which they are part

Administration and Management
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Fernàndez Garberi, Caterina

Institutions of which they are part

Administration and Management
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Related news

A Vall d’Hebron study, carried out at Cemcat, shows that the risk of inflammatory activity increases after discontinuing treatment, but is considerably reduced in people over 60 years of age.

The project will analyse the functional activation of the NLRP3 inflammasome to advance the early identification of patients at risk of insufficient response to S1P receptor-modulating therapies.

Anti-Müllerian hormone had been proposed as a potential biomarker for predicting disease prognosis in women, but this study shows that the observed association is explained by patients’ chronological age.

Related professionals

Núria García Doladé

Núria García Doladé

Predoctoral researcher
Clinical Pharmacology
Read more
Stefania Orlando

Stefania Orlando

Main researcher
Molecular Imaging and Therapy
Read more
Cristina Aguilera Martin

Cristina Aguilera Martin

Main researcher
Clinical Pharmacology
Read more
Dennisse Moggia Morla

Dennisse Moggia Morla

Research technician
Therapeutics and Innovations in Neuropediatrics and other paediatric rare diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.